Complexes between CD40 and compounds comprising benzimidazole moieties
US-12474348-B2 · Nov 18, 2025 · US
This page is not indexed by search engines while we improve data quality.
Porter John Robert patents
Porter John Robert is listed as an inventor on 60 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Porter John Robert |
| Total patents | 60 |
| First publication | Jun 4, 2015 |
| Latest publication | Nov 18, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Antibody epitope
US-2025270308-A1 · Aug 28, 2025 · US
Mechanism of action
US-2025012807-A1 · Jan 9, 2025 · US
Methods of use of anti-TNFα antibodies
US-12055549-B2 · Aug 6, 2024 · US
Modulator assay
US-2023194541-A1 · Jun 22, 2023 · US
Method of identifying potential inhibitors of APO TNFα trimers
US-11674967-B2 · Jun 13, 2023 · US
Method for identifying a modulator of the TNFα or CD40L interaction with their cognate receptors
US-11448655-B2 · Sep 20, 2022 · US
Antibody epitope
US-2022074947-A1 · Mar 10, 2022 · US
Antibody epitope
US-2022025033-A1 · Jan 27, 2022 · US
Antibody against trimeric TNFα complex
US-11174311-B2 · Nov 16, 2021 · US
Recent patents
Latest publications not already listed above.
Antibodies binding to trimeric TNF alpha epitopes
US-11022614-B2 · Jun 1, 2021 · US
Mechanism of action
US-2021140972-A1 · May 13, 2021 · US
Antibody
US-2021132079-A1 · May 6, 2021 · US
Complexes between anti-TNF antibodies, trimeric TNF proteins and organic molecules binding them
US-10969393-B2 · Apr 6, 2021 · US
NOVEL TNFa STRUCTURE FOR USE IN THERAPY
US-2021088530-A1 · Mar 25, 2021 · US
Methods of identifying signaling modulators of the trimeric TNFa
US-10883996-B2 · Jan 5, 2021 · US
Modulator assay
US-2020400678-A1 · Dec 24, 2020 · US
Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimers
US-10775385-B2 · Sep 15, 2020 · US
TNF receptor signaling modulator assay
US-10705094-B2 · Jul 7, 2020 · US
Antibody epitope
US-2019330327-A1 · Oct 31, 2019 · US
Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activity
US-10287299-B2 · May 14, 2019 · US
Tetrahydrobenzimidazole derivatives as modulators of TNF activity
US-10093652-B2 · Oct 9, 2018 · US
NOVEL TNFalpha STRUCTURE FOR USE IN THERAPY
US-2018231562-A1 · Aug 16, 2018 · US
Mechanism of action
US-2018203016-A1 · Jul 19, 2018 · US
Antibody
US-2018171008-A1 · Jun 21, 2018 · US
Antibody epitope
US-2018172701-A1 · Jun 21, 2018 · US
Modulator assay
US-2018172702-A1 · Jun 21, 2018 · US
Purine derivatives as modulators of TNF activity
US-9988383-B2 · Jun 5, 2018 · US
Benzoxazinone Derivatives and Analogues Thereof as Modulators of TNF Activity
US-2018134728-A1 · May 17, 2018 · US
Tetrahydroimidazopyridine derivatives as modulators of TNF activity
US-9969728-B2 · May 15, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ucb Biopharma Sprl | 41 |
| UCB Biopharma SRL | 19 |
| Sanofi Sa | 8 |
| Novartis Ag | 1 |
| Ucb Biopharma Sprl A Corp | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 60 |
| C07D471/04 | 41 |
| A61P37/00 | 39 |
| A61P29/00 | 38 |
| A61P9/00 | 36 |